{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:21:03Z","timestamp":1792102863950,"version":"4.4.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2017,2,21]],"date-time":"2017-02-21T00:00:00Z","timestamp":1487635200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1208\/s12249-017-0710-8","type":"journal-article","created":{"date-parts":[[2017,2,21]],"date-time":"2017-02-21T14:47:35Z","timestamp":1487688455000},"page":"2517-2528","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":74,"title":["PLGA Nanoparticles as Subconjunctival Injection for Management of Glaucoma"],"prefix":"10.1208","volume":"18","author":[{"given":"Hamed A.","family":"Salama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Ghorab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azza A.","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayssa","family":"Abdel Hady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,21]]},"reference":[{"issue":"Suppl 1","key":"710_CR1","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0039-6257(02)00291-6","volume":"47","author":"JB Soltau","year":"2002","unstructured":"Soltau JB, Zimmerman TJ. Changing paradigms in the medical treatment of glaucoma. Surv Ophthalmol. 2002;47 Suppl 1:2\u20135.","journal-title":"Surv Ophthalmol"},{"key":"710_CR2","first-page":"354","volume":"28","author":"JX Koliopoulos","year":"1996","unstructured":"Koliopoulos JX. Time as a risk factor for primary open-angle glaucoma: a scientific and philosophical approach. Ann Ophthalmol. 1996;28:354\u20136.","journal-title":"Ann Ophthalmol"},{"issue":"14","key":"710_CR3","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/j.addr.2005.09.004","volume":"57","author":"PM Hughes","year":"2005","unstructured":"Hughes PM, Olejnik O, Chang-Lin JE, Wilson CG. Topical and systemic drug delivery to the posterior segments. Adv Drug Deliv Rev. 2005;57(14):2010\u201332.","journal-title":"Adv Drug Deliv Rev"},{"issue":"4","key":"710_CR4","first-page":"584","volume":"26","author":"I Ahmed","year":"1985","unstructured":"Ahmed I, Patton TF. Importance of the noncorneal absorption route in topical ophthalmic drug delivery. Invest Ophthalmol Vis Sci. 1985;26(4):584\u20137.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"710_CR5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.5005\/jp-journals-10008-1061","volume":"3","author":"P Ichhpujani","year":"2009","unstructured":"Ichhpujani P, Ramasubramanian A. Ocular surface changes with long-term topical antiglaucoma medications. JOCGP. 2009;3(3):19\u201326.","journal-title":"JOCGP"},{"issue":"Suppl 9","key":"710_CR6","first-page":"15","volume":"88","author":"S Ausayakhun","year":"2005","unstructured":"Ausayakhun S, Yuvaves P, Ngamtiphakom S, Prasitsilp J. Treatment of cytomegalovirus retinitis in AIDS patients with intravitreal ganciclovir. J Med Assoc Thai. 2005;88 Suppl 9:15\u201320.","journal-title":"J Med Assoc Thai"},{"issue":"1","key":"710_CR7","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1517\/17425247.1.1.99","volume":"1","author":"S Raghava","year":"2004","unstructured":"Raghava S, Hammond M, Kompella UB. Periocular routes for retinal drug delivery. Expert Opin Drug Deliv. 2004;1(1):99\u2013114.","journal-title":"Expert Opin Drug Deliv"},{"issue":"2","key":"710_CR8","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1517\/17425247.3.2.261","volume":"3","author":"T Yasukawa","year":"2006","unstructured":"Yasukawa T, Ogura Y, Kimura H, Sakurai E, Tabata Y. Drug delivery from ocular implants. Expert Opin Drug Deliv. 2006;3(2):261\u201373.","journal-title":"Expert Opin Drug Deliv"},{"issue":"2","key":"710_CR9","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/IJG.0b013e31814b990d","volume":"17","author":"D Ghate","year":"2008","unstructured":"Ghate D, Edelhauser HF. Barriers to glaucoma drug delivery. J Glaucoma. 2008;17(2):147\u201356.","journal-title":"J Glaucoma"},{"issue":"23","key":"710_CR10","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.2174\/138161209788923886","volume":"15","author":"S Wadhwa","year":"2009","unstructured":"Wadhwa S, Paliwal R, Paliwal SR, Vyas SP. Nanocarriers in ocular drug delivery: an update review. Curr Pharm Des. 2009;15(23):2724\u201350.","journal-title":"Curr Pharm Des"},{"issue":"8","key":"710_CR11","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.jcrs.2005.08.017","volume":"31","author":"SY Lee","year":"2005","unstructured":"Lee SY, Chee SP. Surodex after phacoemulsification. J Cataract Refract Surg. 2005;31(8):1479\u201380.","journal-title":"J Cataract Refract Surg"},{"issue":"15","key":"710_CR12","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1517\/14656560903160671","volume":"10","author":"DF Kiernan","year":"2009","unstructured":"Kiernan DF, Mieler WF. The use of intraocular corticosteroids. Expert Opin Pharmacother. 2009;10(15):2511\u201325.","journal-title":"Expert Opin Pharmacother"},{"issue":"5","key":"710_CR13","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s11095-008-9694-0","volume":"26","author":"R Gaudana","year":"2009","unstructured":"Gaudana R, Jwala J, Boddu SH, Mitra AK. Recent perspectives in ocular drug delivery. Pharm Res. 2009;26(5):1197\u2013216.","journal-title":"Pharm Res"},{"issue":"1","key":"710_CR14","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.nano.2008.07.003","volume":"5","author":"SM Agnihotri","year":"2009","unstructured":"Agnihotri SM, Vavia PR. Diclofenac-loaded biopolymeric nanosuspensions for ophthalmic application. Nanomed: Nanotechnol, Biol Med. 2009;5(1):90\u20135.","journal-title":"Nanomed: Nanotechnol, Biol Med"},{"issue":"4","key":"710_CR15","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.exer.2006.04.014","volume":"83","author":"H Li","year":"2006","unstructured":"Li H, Tran VV, Hu Y, Saltzman WM, Barnstable CJ, Tombran-Tink J. A PEDF N-terminal peptide protects the retina from ischemic injury when delivered in PLGA nanospheres. Exp Eye Res. 2006;83(4):824\u201333.","journal-title":"Exp Eye Res"},{"issue":"1","key":"710_CR16","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1080\/02652040802095250","volume":"26","author":"JP Bertram","year":"2009","unstructured":"Bertram JP, Saluja SS, McKain J, Lavik EB. Sustained delivery of timolol maleate from poly(lactic-co-glycolic acid)\/poly(lactic acid) microspheres for over 3 months. J Microencapsul. 2009;26(1):18\u201326.","journal-title":"J Microencapsul"},{"key":"710_CR17","unstructured":"Kreuter J. Nanoparticles. Colloidal Drug Deliv Syst. 1994:219\u2013342."},{"issue":"2","key":"710_CR18","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.nano.2009.10.004","volume":"6","author":"H Gupta","year":"2010","unstructured":"Gupta H, Aqil M, Khar RK, Ali A, Bhatnagar A, Mittal G. Sparfloxacin-loaded PLGA nanoparticles for sustained ocular drug delivery. Nanomed: Nanotechnol, Biol Med. 2010;6(2):324\u201333.","journal-title":"Nanomed: Nanotechnol, Biol Med"},{"issue":"6","key":"710_CR19","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3109\/1061186X.2010.504268","volume":"19","author":"H Gupta","year":"2011","unstructured":"Gupta H, Aqil M, Khar R, Ali A, Bhatnagar A, Mittal G. Biodegradable levofloxacin nanoparticles for sustained ocular drug delivery. J Drug Target. 2011;19(6):409\u201317.","journal-title":"J Drug Target"},{"issue":"1","key":"710_CR20","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.colsurfb.2009.03.028","volume":"72","author":"J Ara\u00fajo","year":"2009","unstructured":"Ara\u00fajo J, Vega E, Lopes C, Egea M, Garcia M, Souto E. Effect of polymer viscosity on physicochemical properties and ocular tolerance of FB-loaded PLGA nanospheres. Colloids Surf B: Biointerfaces. 2009;72(1):48\u201356.","journal-title":"Colloids Surf B: Biointerfaces"},{"issue":"2","key":"710_CR21","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ejphar.2005.02.019","volume":"511","author":"SP Ayalasomayajula","year":"2005","unstructured":"Ayalasomayajula SP, Kompella UB. Subconjunctivally administered celecoxib-PLGA microparticles sustain retinal drug levels and alleviate diabetes-induced oxidative stress in a rat model. Eur J Pharmacol. 2005;511(2):191\u20138.","journal-title":"Eur J Pharmacol"},{"key":"710_CR22","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.exer.2013.04.007","volume":"112","author":"A Giarmoukakis","year":"2013","unstructured":"Giarmoukakis A, Labiris G, Sideroudi H, Tsimali Z, Koutsospyrou N, Avgoustakis K, et al. Biodegradable nanoparticles for controlled subconjunctival delivery of latanoprost acid: in vitro and in vivo evaluation. preliminary results. Exp Eye Res. 2013;112:29\u201336.","journal-title":"Exp Eye Res"},{"issue":"10","key":"710_CR23","doi-asserted-by":"crossref","first-page":"4360","DOI":"10.1016\/j.actbio.2014.05.031","volume":"10","author":"YH Cheng","year":"2014","unstructured":"Cheng YH, Hung KH, Tsai TH, Lee CJ, Ku RY, Chiu AW, et al. Sustained delivery of latanoprost by thermosensitive chitosan-gelatin-based hydrogel for controlling ocular hypertension. Acta Biomater. 2014;10(10):4360\u20136.","journal-title":"Acta Biomater"},{"key":"710_CR24","first-page":"123","volume":"7","author":"JV Natarajan","year":"2012","unstructured":"Natarajan JV, Ang M, Darwitan A, Chattopadhyay S, Wong TT, Venkatraman SS. Nanomedicine for glaucoma: liposomes provide sustained release of latanoprost in the eye. Int J Nanomedicine. 2012;7:123\u201331.","journal-title":"Int J Nanomedicine"},{"issue":"3","key":"710_CR25","first-page":"16","volume":"5","author":"B Nagavarma","year":"2012","unstructured":"Nagavarma B, Yadav HK, Ayaz A, Vasudha L, Shivakumar H. Different techniques for preparation of polymeric nanoparticles\u2014a review. Asian J Pharm Clin Res. 2012;5(3):16\u201323.","journal-title":"Asian J Pharm Clin Res"},{"issue":"5","key":"710_CR26","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1208\/s12249-015-0448-0","volume":"17","author":"AH Salama","year":"2016","unstructured":"Salama AH, Mahmoud AA, Kamel R. A novel method for preparing surface-modified fluocinolone acetonide loaded plga nanoparticles for ocular use: in vitro and in vivo evaluations. AAPS PharmSciTech. 2016;17(5):1159\u201372.","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"710_CR27","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.2042-7158.1975.tb09378.x","volume":"27","author":"KA Khan","year":"1975","unstructured":"Khan KA. The concept of dissolution efficiency. J Pharm Pharmacol. 1975;27(1):48\u20139.","journal-title":"J Pharm Pharmacol"},{"issue":"6","key":"710_CR28","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/00061198-200412000-00005","volume":"13","author":"AP Wells","year":"2004","unstructured":"Wells AP, Crowston JG, Marks J, Kirwan JF, Smith G, Clarke JC, et al. A pilot study of a system for grading of drainage blebs after glaucoma surgery. J Glaucoma. 2004;13(6):454\u201360.","journal-title":"J Glaucoma"},{"issue":"1","key":"710_CR29","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0927-7757(00)00825-6","volume":"182","author":"H-Y Kwon","year":"2001","unstructured":"Kwon H-Y, Lee J-Y, Choi S-W, Jang Y, Kim J-H. Preparation of PLGA nanoparticles containing estrogen by emulsification\u2013diffusion method. Colloids Surf A Physicochem Eng Asp. 2001;182(1):123\u201330.","journal-title":"Colloids Surf A Physicochem Eng Asp"},{"issue":"4","key":"710_CR30","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S1359-0286(02)00117-1","volume":"6","author":"ML Hans","year":"2002","unstructured":"Hans ML, Lowman AM. Biodegradable nanoparticles for drug delivery and targeting. Curr Opin Solid State Mater Sci. 2002;6(4):319\u201327.","journal-title":"Curr Opin Solid State Mater Sci"},{"key":"710_CR31","unstructured":"Inoue J, Shah T, inventors; Senju Usa, Inc., assignee. Ophthalmic composition. California patent US 8211450. 2012."},{"issue":"1-2","key":"710_CR32","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ijpharm.2007.08.034","volume":"350","author":"X Song","year":"2008","unstructured":"Song X, Zhao Y, Wu W, Bi Y, Cai Z, Chen Q, et al. PLGA nanoparticles simultaneously loaded with vincristine sulfate and verapamil hydrochloride: systematic study of particle size and drug entrapment efficiency. Int J Pharm. 2008;350(1-2):320\u20139.","journal-title":"Int J Pharm"},{"issue":"1-2","key":"710_CR33","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0378-5173(02)00058-3","volume":"238","author":"J Vandervoort","year":"2002","unstructured":"Vandervoort J, Ludwig A. Biocompatible stabilizers in the preparation of PLGA nanoparticles: a factorial design study. Int J Pharm. 2002;238(1-2):77\u201392.","journal-title":"Int J Pharm"},{"issue":"7","key":"710_CR34","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1002\/jps.10412","volume":"92","author":"MA Moreno","year":"2003","unstructured":"Moreno MA, Ballesteros MP, Frutos P. Lecithin-based oil-in-water microemulsions for parenteral use: pseudoternary phase diagrams, characterization and toxicity studies. J Pharm Sci. 2003;92(7):1428\u201337.","journal-title":"J Pharm Sci"},{"issue":"21","key":"710_CR35","doi-asserted-by":"crossref","first-page":"5762","DOI":"10.1021\/la962108r","volume":"13","author":"PD Huibers","year":"1997","unstructured":"Huibers PD, Shah D. Evidence for synergism in nonionic surfactant mixtures: enhancement of solubilization in water-in-oil microemulsions. Langmuir. 1997;13(21):5762\u20135.","journal-title":"Langmuir"},{"key":"710_CR36","doi-asserted-by":"crossref","first-page":"5855","DOI":"10.1021\/j150668a023","volume":"88","author":"BW Ninham","year":"1984","unstructured":"Ninham BW, Chen SJ, Evans DF. Role of oils and other factors in microemulsion design. J Phys Chem. 1984;88:5855\u20137.","journal-title":"J Phys Chem"},{"issue":"2","key":"710_CR37","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1089\/jop.2012.0069","volume":"29","author":"K Hippalgaonkar","year":"2013","unstructured":"Hippalgaonkar K, Adelli GR, Repka MA, Majumdar S. Indomethacin-loaded solid lipid nanoparticles for ocular delivery: development, characterization, and in vitro evaluation. J Ocul Pharmacol Ther. 2013;29(2):216\u201328.","journal-title":"J Ocul Pharmacol Ther"},{"issue":"7","key":"710_CR38","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3109\/02713681003760168","volume":"35","author":"EB Souto","year":"2010","unstructured":"Souto EB, Doktorovova S, Gonzalez-Mira E, Egea MA, Garcia ML. Feasibility of lipid nanoparticles for ocular delivery of anti-inflammatory drugs. Curr Eye Res. 2010;35(7):537\u201352.","journal-title":"Curr Eye Res"},{"issue":"2","key":"710_CR39","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0939-6411(01)00230-2","volume":"53","author":"M Trotta","year":"2002","unstructured":"Trotta M, Pattarino F, Ignoni T. Stability of drug-carrier emulsions containing phosphatidylcholine mixtures. Eur J Pharm Biopharm. 2002;53(2):203\u20138.","journal-title":"Eur J Pharm Biopharm"},{"key":"710_CR40","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s10965-013-0110-z","volume":"20","author":"M Azizi","year":"2013","unstructured":"Azizi M, Farahmandghavi F, Joghataei M, Zandi M, Imani M, Bakhtiary M, et al. Fabrication of protein-loaded PLGA nanoparticles: effect of selected formulation variables on particle size and release profile. J Polym Res. 2013;20:110\u201323.","journal-title":"J Polym Res"},{"issue":"6","key":"710_CR41","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1016\/j.ejmech.2008.09.045","volume":"44","author":"S Khoee","year":"2009","unstructured":"Khoee S, Yaghoobian M. An investigation into the role of surfactants in controlling particle size of polymeric nanocapsules containing penicillin-G in double emulsion. Eur J Med Chem. 2009;44(6):2392\u20139.","journal-title":"Eur J Med Chem"},{"issue":"6","key":"710_CR42","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1016\/j.actbio.2009.11.035","volume":"6","author":"Y Zhang","year":"2010","unstructured":"Zhang Y, Tang L, Sun L, Bao J, Song C, Huang L, et al. A novel paclitaxel-loaded poly(epsilon-caprolactone)\/Poloxamer 188 blend nanoparticle overcoming multidrug resistance for cancer treatment. Acta Biomater. 2010;6(6):2045\u201352.","journal-title":"Acta Biomater"},{"issue":"3","key":"710_CR43","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1208\/s12249-010-9489-6","volume":"11","author":"M Cetin","year":"2010","unstructured":"Cetin M, Atila A, Kadioglu Y. Formulation and in-vitro characterization of Eudragit(R) L100 and Eudragit(R) L100-PLGA nanoparticles containing diclofenac sodium. AAPS Pharm-Sci Tech. 2010;11(3):1250\u20136.","journal-title":"AAPS Pharm-Sci Tech"},{"issue":"2","key":"710_CR44","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ejpb.2008.01.013","volume":"69","author":"X Song","year":"2008","unstructured":"Song X, Zhao Y, Hou S, Xu F, Zhao R, He J, et al. Dual agents loaded PLGA nanoparticles: systematic study of particle size and drug entrapment efficiency. Eur J Pharm Biopharm. 2008;69(2):445\u201353.","journal-title":"Eur J Pharm Biopharm"},{"issue":"2","key":"710_CR45","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/BF02707148","volume":"17","author":"J-W Nah","year":"2000","unstructured":"Nah J-W, Jeong Y-D, Koh J-J. Drug release from nanoparticles of Poly (DL-lactide-co-glycolide). Korean J Chem Eng. 2000;17(2):230\u20136.","journal-title":"Korean J Chem Eng"},{"issue":"6","key":"710_CR46","doi-asserted-by":"crossref","first-page":"065002","DOI":"10.1088\/1748-6041\/5\/6\/065002","volume":"5","author":"J Liu","year":"2010","unstructured":"Liu J, Qiu Z, Wang S, Zhou L, Zhang S. A modified double-emulsion method for the preparation of daunorubicin-loaded polymeric nanoparticle with enhanced in vitro anti-tumor activity. Biomed Mater. 2010;5(6):065002.","journal-title":"Biomed Mater"},{"issue":"5153","key":"710_CR47","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1126\/science.8128245","volume":"263","author":"R Gref","year":"1994","unstructured":"Gref R, Minamitake Y, Peracchia MT, Trubetskoy V, Torchilin V, Langer R. Biodegradable long-circulating polymeric nanospheres. Science. 1994;263(5153):1600\u20133.","journal-title":"Science"},{"issue":"1","key":"710_CR48","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.colsurfb.2009.08.043","volume":"75","author":"R Manchanda","year":"2010","unstructured":"Manchanda R, Fernandez-Fernandez A, Nagesetti A, McGoron AJ. Preparation and characterization of a polymeric (PLGA) nanoparticulate drug delivery system with simultaneous incorporation of chemotherapeutic and thermo-optical agents. Colloids Surf B: Biointerfaces. 2010;75(1):260\u20137.","journal-title":"Colloids Surf B: Biointerfaces"},{"issue":"4","key":"710_CR49","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jsps.2011.05.001","volume":"19","author":"S Koocheki","year":"2011","unstructured":"Koocheki S, Madaeni SS, Niroomandi P. Development of an enhanced formulation for delivering sustained release of buprenorphine hydrochloride. Saudi Pharm J. 2011;19(4):255\u201362.","journal-title":"Saudi Pharm J"},{"issue":"2","key":"710_CR50","doi-asserted-by":"crossref","first-page":"57","DOI":"10.4103\/0973-8398.84545","volume":"5","author":"A Soni","year":"2011","unstructured":"Soni A, Gadad A, Dandagi P, Mastiholimath V. Simvastatin-loaded PLGA nanoparticles for improved oral bioavailability and sustained release: Effect of formulation variables. Asian J Pharm. 2011;5(2):57\u201364.","journal-title":"Asian J Pharm"},{"key":"710_CR51","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1477-3155-10-20","volume":"10","author":"N Pirooznia","year":"2012","unstructured":"Pirooznia N, Hasannia S, Lotfi AS, Ghanei M. Encapsulation of alpha-1 antitrypsin in PLGA nanoparticles: in vitro characterization as an effective aerosol formulation in pulmonary diseases. J Nanobiotechnology. 2012;10:20\u201335.","journal-title":"J Nanobiotechnology"},{"issue":"4","key":"710_CR52","doi-asserted-by":"crossref","first-page":"422","DOI":"10.2174\/157341310791658937","volume":"6","author":"S Jain","year":"2010","unstructured":"Jain S, Mittal A, Jain A, Mahajan R, Singh D. Cyclosporin A loaded PLGA nanoparticle: preparation, optimization, in-vitro characterization and stability studies. Curr Nanosci. 2010;6(4):422\u201331.","journal-title":"Curr Nanosci"},{"issue":"10","key":"710_CR53","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1358\/mf.2007.29.10.1147765","volume":"29","author":"S Gupta","year":"2007","unstructured":"Gupta S, Agarwal R, Galpalli N, Srivastava S, Agrawal S, Saxena R. Comparative efficacy of pilocarpine, timolol and latanoprost in experimental models of glaucoma. Methods Find Exp Clin Pharmacol. 2007;29(10):665\u201372.","journal-title":"Methods Find Exp Clin Pharmacol"},{"issue":"1","key":"710_CR54","first-page":"29","volume":"7","author":"AA Sarchahi","year":"2012","unstructured":"Sarchahi AA, Bozorgi H. Effect of tetracaine on intraocular pressure in normal and hypertensive rabbit eyes. J Ophthalmic Vision Res. 2012;7(1):29.","journal-title":"J Ophthalmic Vision Res"},{"key":"710_CR55","doi-asserted-by":"crossref","unstructured":"Bouhenni AR, Dunmire J, Sewell A, Edward DP. Animal models of glaucoma. BioMed Res Int. 2012;2012.","DOI":"10.1155\/2012\/692609"},{"issue":"1","key":"710_CR56","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.nano.2005.12.003","volume":"2","author":"C Pinto Reis","year":"2006","unstructured":"Pinto Reis C, Neufeld RJ, Ribeiro AJ, Veiga F. Nanoencapsulation I. methods for preparation of drug-loaded polymeric nanoparticles. Nanomedicine. 2006;2(1):8\u201321.","journal-title":"Nanomedicine"},{"issue":"6","key":"710_CR57","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.preteyeres.2010.08.002","volume":"29","author":"Y Diebold","year":"2010","unstructured":"Diebold Y, Calonge M. Applications of nanoparticles in ophthalmology. Prog Retin Eye Res. 2010;29(6):596\u2013609.","journal-title":"Prog Retin Eye Res"},{"issue":"01","key":"710_CR58","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4236\/jbnb.2015.61002","volume":"6","author":"ATCR Silva","year":"2015","unstructured":"Silva ATCR, Cardoso BCO, e Silva MESR, Freitas RFS, Sousa RG. Synthesis, characterization, and study of PLGA copolymer in vitro degradation. J Biomater Nanobiotechnol. 2015;6(01):8\u201319.","journal-title":"J Biomater Nanobiotechnol"},{"issue":"11","key":"710_CR59","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.addr.2006.07.026","volume":"58","author":"JL Bourges","year":"2006","unstructured":"Bourges JL, Bloquel C, Thomas A, Froussart F, Bochot A, Azan F, et al. Intraocular implants for extended drug delivery: therapeutic applications. Adv Drug Deliv Rev. 2006;58(11):1182\u2013202.","journal-title":"Adv Drug Deliv Rev"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1208\/s12249-017-0710-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-017-0710-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-017-0710-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T19:12:59Z","timestamp":1568833979000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/s12249-017-0710-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,21]]},"references-count":59,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["710"],"URL":"https:\/\/doi.org\/10.1208\/s12249-017-0710-8","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,21]]}}}